Interestingly, RSL3 and Erastin cause a decrease in GPX4 in nasopharyngeal carcinoma cells (CNE-2) without affecting cell viability, ROS levels, and cell death (Figure 1, Figure 3, Figure 4 and Figure 5). This evidence concerns the gene GPX4 and nasopharyngeal carcinoma.